6,029
Total Claims
$993K
Drug Cost
769
Beneficiaries
$1,292
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-15%
Cost per patient vs peers
$1,292 vs $1,524 avg
+19%
Brand preference vs peers
16.2% vs 13.7% avg
Brand vs Generic
84% generic
Brand: 979 claims · $872K
Generic: 5,050 claims · $121K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 386 | $421K |
| Rivaroxaban | 157 | $161K |
| Sacubitril/Valsartan | 125 | $130K |
| Ticagrelor | 66 | $53K |
| Evolocumab | 59 | $44K |
| Evolocumab | 31 | $23K |
| Dronedarone Hcl | 13 | $20K |
| Ranolazine | 73 | $11K |
| Valsartan | 168 | $7,756 |
| Nifedipine | 158 | $7,090 |
| Metoprolol Succinate | 355 | $6,746 |
| Clopidogrel Bisulfate | 327 | $5,402 |
| Atorvastatin Calcium | 357 | $5,365 |
| Nebivolol Hcl | 77 | $5,332 |
| Nitroglycerin | 154 | $5,159 |
Prescribing Profile
48
Unique Drugs
$712K
Patient Profile
74
Avg Age
53%
Female
1.78
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About